La maladie de Parkinson en France (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Antiparkinson Agents (therapeutic use) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antiparkinson Agents (pharmacology) < Antiparkinson Agents (therapeutic use) < Antiparkinson Agents (toxicity)  Facettes :

List of bibliographic references indexed by Antiparkinson Agents (therapeutic use)

Number of relevant bibliographic references: 225.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000182 (2016) Leslie Mazuel [France] ; Carine Chassain [France] ; Betty Jean [France] ; Bruno Pereira [France] ; Aurélie Cladière [France] ; Claudine Speziale [France] ; Franck Durif [France]Proton MR Spectroscopy for Diagnosis and Evaluation of Treatment Efficacy in Parkinson Disease.
000248 (2016) Jean-Marc Taymans [France] ; Elisa Greggio [Italie]LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson’s Disease, Where Do We Stand?
000315 (2016) Clément François [États-Unis] ; Robert A. Hauser [États-Unis] ; Samuel Aballéa [France] ; Julie Dorey [États-Unis] ; Elizaveta Kharitonova [France] ; L Arthur Hewitt [États-Unis]Cost-effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post-hoc economic analysis of Phase 3 clinical trial data.
000373 (2016) N. Simon [France] ; F. Viallet [France] ; A. Boulamery [France] ; A. Eusebio [France] ; D. Gayraud [France] ; J-P Azulay [France]A combined pharmacokinetic/pharmacodynamic model of levodopa motor response and dyskinesia in Parkinson's disease patients.
000498 (2015) Mathieu Anheim [France] ; Patricia Dowsey-Limousin [France] ; Paul Krack [France] ; Stéphan Chabardès [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France]Subthalamic stimulation or subthalamic lesion for Parkinson's disease? A case report.
000511 (2015) Romain Lefaucheur [France] ; Floriane Le Goff [France] ; Gaëlle Gaillon [France] ; Aude Triquenot-Bagan [France] ; David Maltête [France]Severe dizziness following rivaroxaban introduction in a parkinsonian patient: Drug-drug interaction?
000515 (2015) Emma D. Deeks [Oman]Safinamide: first global approval.
000535 (2015) Robert A. Hauser [États-Unis] ; Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Susan B. Huyck [États-Unis] ; Rachel Capece [États-Unis] ; Tony W. Ho [États-Unis] ; Peter Sklar [États-Unis] ; Christopher Lines [États-Unis] ; David Michelson [États-Unis] ; David Hewitt [États-Unis]Preladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease: Two Randomized Clinical Trials and Lessons Learned.
000608 (2015) Clive Ballard [Royaume-Uni] ; Stuart Isaacson [États-Unis] ; Roger Mills [États-Unis] ; Hilde Williams [États-Unis] ; Anne Corbett [Royaume-Uni] ; Bruce Coate [États-Unis] ; Rajesh Pahwa [États-Unis] ; Olivier Rascol [France] ; David J. Burn [Royaume-Uni]Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis.
000644 (2015) Ana Marques [France] ; Maria Livia Fantini [France] ; Dominique Morand [France] ; Bruno Pereira [France] ; Philippe Derost [France] ; Miguel Ulla [France] ; Bérengère Debilly [France] ; Jean-Jacques Lemaire [France] ; Franck Durif [France]Emergence of restless legs syndrome after subthalamic stimulation in Parkinson's disease: a dopaminergic overstimulation?
000652 (2015) Hayat Belaid [France] ; Joelle Adrien [France] ; Carine Karachi [France] ; Etienne C. Hirsch [France] ; Chantal François [France]Effect of melatonin on sleep disorders in a monkey model of Parkinson's disease.
000659 (2015) Antoine Moulignier [France] ; Antoine Gueguen ; François-Xavier Lescure ; Marc Ziegler ; Pierre-Marie Girard ; Bernard Cardon ; Gilles Pialoux ; Jean-Michel Molina ; Jean-Philippe Brandel ; Cédric LamirelDoes HIV Infection Alter Parkinson Disease?
000804 (2014) P. Cesaro [France] ; L. Defebvre [France][Drug treatment of early-stage (de novo and "honeymoon") Parkinson disease].
000805 (2014) M. Rambour [France] ; C. Moreau [France] ; J. Salleron [France] ; D. Devos [France] ; A. Kreisler [France] ; E. Mutez [France] ; C. Simonin [France] ; A. Annic [France] ; K. Dujardin [France] ; A. Destée [France] ; L. Defebvre [France][Continuous subcutaneous infusion of apomorphine in Parkinson's disease: retrospective analysis of a series of 81 patients].
000808 (2014) Fabienne Ory-Magne [France] ; Jean-Christophe Corvol ; Jean-Philippe Azulay ; Anne-Marie Bonnet ; Christine Brefel-Courbon ; Philippe Damier ; Estelle Dellapina ; Alain Destée [France] ; Franck Durif ; Monique Galitzky ; Thibaud Lebouvier ; Wassilios Meissner ; Claire Thalamas ; François Tison ; Alexandrine Salis ; Agnès Sommet ; François Viallet ; Marie Vidailhet ; Olivier RascolWithdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial.
000839 (2014) Damien Benis [France] ; Olivier David [France] ; Jean-Philippe Lachaux [France] ; Eric Seigneuret [France] ; Paul Krack [France] ; Valérie Fraix [France] ; Stéphan Chabardès [France] ; Julien Bastin [France]Subthalamic nucleus activity dissociates proactive and reactive inhibition in patients with Parkinson's disease.
000842 (2014) Serge Pinto [France] ; Murielle Ferraye [Pays-Bas] ; Robert Espesser [France] ; Valérie Fraix [France] ; Audrey Maillet [France] ; Jennifer Guirchoum [France] ; Deborah Layani-Zemour [France] ; Alain Ghio [France] ; Stéphan Chabardès [France] ; Pierre Pollak [Suisse] ; Bettina Debû [France]Stimulation of the pedunculopontine nucleus area in Parkinson's disease: effects on speech and intelligibility.
000853 (2014) Martial Mallaret [France] ; Ouhaid Lagha-Boukbiza ; Saskia Biskup ; Izzie Jacques Namer ; Gabrielle Rudolf ; Mathieu Anheim ; Christine TranchantSPG15: a cause of juvenile atypical levodopa responsive parkinsonism.
000863 (2014) Marlene C. Hechtner [Allemagne] ; Thomas Vogt [Allemagne] ; York Zöllner [Allemagne] ; Sabrina Schröder [Suède] ; Julia B. Sauer [États-Unis] ; Harald Binder [Allemagne] ; Susanne Singer [Allemagne] ; Rafael Mikolajczyk [Allemagne]Quality of life in Parkinson's disease patients with motor fluctuations and dyskinesias in five European countries.
000875 (2014) Sylvia Navailles [France] ; Giuseppe Di Giovanni ; Philippe De DeurwaerdèrePredicting dopaminergic effects of L-DOPA in the treatment for Parkinson's disease.
000895 (2014) Olivier Rascol [France]Parkinson disease: Can a new trial end controversy over when to use levodopa?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Antiparkinson Agents (therapeutic use)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Antiparkinson Agents (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiparkinson Agents (therapeutic use)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024